I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Restatis (ciclosporin 0.05% eye drops) is considered to be a RED drug and initiation and continuation of supply should be from a specialist clinician.
The local guidance below was updated in December 2016 in relation to ciclosporin preparations following the publication of NICE guidance for Ikervis (ciclosporin 1% eye drops)
